Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1)

GP340; SAG; Muclin; Glycoprotein 340; Hensin; Salivary agglutinin; Surfactant pulmonary-associated D-binding protein

  • Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1) Packages (Simulation)
  • Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1) Packages (Simulation)
  • Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1) Figure. Gene Sequencing (Extract)
  • RPJ251Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1)

USAGE of the Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPJ251Hu01 Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1) Positive Control; Immunogen; SDS-PAGE; WB.
PAJ251Hu01 Polyclonal Antibody to Deleted In Malignant Brain Tumors 1 (DMBT1) WB; IHC; ICC; IP.
MAJ251Hu21 Monoclonal Antibody to Deleted In Malignant Brain Tumors 1 (DMBT1) WB; IHC; ICC; IP.
SEJ251Hu ELISA Kit for Deleted In Malignant Brain Tumors 1 (DMBT1) Enzyme-linked immunosorbent assay for Antigen Detection.
GUESTBOOK